Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of HNRNPK mRNA | affects expression | 16483693
|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in increased expression of HNRNPK mRNA | increases expression | 12420312
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of HNRNPK protein | decreases expression | 19747914
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of HNRNPK protein | increases expression | 19364129
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of HNRNPK protein | decreases expression | 20097212
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of HNRNPK mRNA | increases expression | 20127859
|
C110772 |
benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone |
benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [NSC606985 results in decreased expression of HNRNPK protein] | decreases expression|decreases reaction | 19747914
|
C072553 |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [NSC606985 results in decreased expression of HNRNPK protein] | decreases expression|decreases reaction | 19747914
|
C072553 |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [PRKCD protein results in increased ubiquitination of HNRNPK protein] | increases reaction|increases ubiquitination | 19747914
|
D003520 |
Cyclophosphamide |
Cyclophosphamide results in increased expression of HNRNPK protein | increases expression | 17475930
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of HNRNPK protein | decreases expression | 19747914
|
C514334 |
NSC606985 |
benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [NSC606985 results in decreased expression of HNRNPK protein] | decreases expression|decreases reaction | 19747914
|
C514334 |
NSC606985 |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [NSC606985 results in decreased expression of HNRNPK protein] | decreases expression|decreases reaction | 19747914
|
C514334 |
NSC606985 |
NSC606985 results in decreased expression of HNRNPK protein | decreases expression | 19747914
|
C514334 |
NSC606985 |
PRKCD protein affects the reaction [NSC606985 results in decreased expression of HNRNPK protein] | affects reaction|decreases expression | 19747914
|
C514334 |
NSC606985 |
PRKCD protein affects the reaction [NSC606985 results in increased cleavage of HNRNPK protein] | affects reaction|increases cleavage | 19747914
|
C514334 |
NSC606985 |
rottlerin inhibits the reaction [NSC606985 results in decreased expression of HNRNPK protein] | decreases expression|decreases reaction | 19747914
|
C085746 |
rottlerin |
rottlerin inhibits the reaction [NSC606985 results in decreased expression of HNRNPK protein] | decreases expression|decreases reaction | 19747914
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.84 | 18287403 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
7.39 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
7.39 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
7.39 | 17418594 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.76 | 6695378 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.78 | 21441931 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.33 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
4.86 | 15014928 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
3.88 | 16206674 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
5.02 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
4.00 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.02 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
2.02 | 12006526 18234424 15136595 11325840 18323546 17388661 17020986 15093573 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.02 | 15668708 19526202 15567936 18628466 11325840 16096432 15692762 16264153 17426702 15136595 16826403 18695136 16115903 15939500 16322301 18382427 16595493 16935488 18234424 17369602 15993339 15994142 15634643 17983394 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.55 | 11589617 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
5.13 | 16051944 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
4.92 | 15553829 16217749 11135700 14691202 15073043 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
4.92 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
4.92 | 16234567 16023760 18059187 17876044 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
5.17 | 16152834 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
5.19 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
7.15 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
7.15 | 16201981 1485588 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.31 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.86 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
4.86 | 6189445 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.66 | 16651473 16278810 16731534 16242529 17351982 17974986 15476868 17382496 17308081 17924179 16269455 16109756 18627295 17007740 17329180 16612575 16364871 15811867 17131338 15792986 17519947 16952015 17928571 15505089 16455267 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
3.00 | 17334414 16243910 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
2.64 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.64 | 18802399 18259882 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.42 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
1.89 | 10525206 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
5.30 | 18433785 10700343 12913760 11948286 18093676 18710439 18372110 18295254 10498854 12161096 15643279 12388444 16614059 18483878 15276878 16413132 16989017 16651033 17979934 17010015 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.32 | 15213294 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
4.24 | 10990075 11751995 15331540 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.27 | 18772604 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
2.49 | 17416283 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.82 | 18602426 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.58 | 17359293 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.47 | 18037988 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.47 | 11006010 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.59 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.59 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
3.49 | 15073043 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.87 | 19069698 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.50 | 16904648 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.47 | 17150277 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.80 | 11389073 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
5.29 | 16376943 11014644 15172196 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.66 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.75 | 20471113 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.62 | 14766674 16144979 16244372 16707910 16495754 16330681 18006777 18674790 16879835 12587719 17875725 16244371 17888722 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.46 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.11 | 15692506 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.55 | 11918545 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.85 | 14986274 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
8.32 | 17606976 16135485 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
8.32 | 15147373 17606976 18501091 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.65 | 16076520 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
3.75 | 16517039 7193160 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
3.16 | 15369732 15699352 16775033 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.36 | 16707910 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
6.91 | 15070760 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
6.91 | 10602166 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.47 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.57 | 17802794 18587576 18172266 17296974 17008537 17658394 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
4.00 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.59 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
9.12 | 14633726 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
9.12 | 10373061 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.97 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.16 | 16467208 16968895 20471514 19850784 17050201 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.34 | 17649720 12018890 16823087 16331271 19075265 15748426 19642359 16966277 17712046 15336539 17107899 17869043 15213294 15622746 16891316 17217047 12712474 16330433 16112521 19225113 9834237 12679006 19035177 11161223 11468182 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.59 | 16882451 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
5.25 | 10052129 11830472 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.15 | 16439617 16595196 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
4.78 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
4.78 | 20195826 21137059 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
6.54 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
6.54 | 16842330 17085340 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.51 | 15213294 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
3.59 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.59 | 17053015 20464547 20064080 18816296 20135361 18569708 20869020 18520028 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
3.59 | 17418594 6189445 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
8.36 | 12854902 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
8.36 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.82 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
9.57 | 11911406 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
9.57 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.83 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.15 | 15458769 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.31 | 16827129 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
5.06 | 16388313 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.13 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.70 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.35 | 16381670 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
5.08 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.25 | 19549372 19417148 11468182 14977855 15949261 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.99 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
3.25 | 16105982 16882451 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
3.02 | 19429709 15857846 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.20 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
3.02 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.56 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
5.56 | 18854779 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
5.03 | 16636307 16899518 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.18 | 16889571 15640375 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
3.24 | 10525206 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
7.53 | 8761367 16115947 15176712 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
7.53 | 15555623 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
5.17 | 8761367 12837982 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.54 | 8291058 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
5.00 | 16517039 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.28 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
2.46 | 19769630 16624393 12452020 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
3.79 | 18093676 12161096 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
5.77 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
5.77 | 11332152 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.38 | 19927285 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.47 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.47 | 17638057 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.91 | 21297632 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.09 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.09 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.09 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.09 | 18437689 16868541 15897917 15749863 16729912 16888761 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.35 | 16636934 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.48 | 17922066 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.18 | 15675481 16767912 17203757 15625365 18313854 17710206 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
11.09 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
11.09 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.08 | 17846226 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
5.04 | 16636934 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
6.09 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
6.09 | 15692506 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.83 | 17203757 16767912 15625365 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.80 | 16517039 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
2.41 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.41 | 20155912 2093021 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
5.34 | 12837982 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
7.86 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
7.86 | 17909728 16010429 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.24 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
12.57 | 12973940 20435036 11780464 12845720 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
12.57 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
12.57 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
12.57 | 17653716 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.48 | 17678736 16364871 17334414 17638931 |